We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$18.1B
AUM Growth
+$2.29B
Cap. Flow
+$1.49B
Cap. Flow %
8.21%
Top 10 Hldgs %
14.26%
Holding
1,826
New
616
Increased
338
Reduced
371
Closed
491

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$219M
2
TWX
Time Warner Inc
TWX
+$207M
3
DGX icon
Quest Diagnostics
DGX
+$161M
4
CVS icon
CVS Health
CVS
+$154M
5
PCG icon
PG&E
PCG
+$143M

Top Sells

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$162M
2
TXN icon
Texas Instruments
TXN
+$103M
3
AMZN icon
Amazon
AMZN
+$85.6M
4
DAL icon
Delta Air Lines
DAL
+$76M
5
NVDA icon
NVIDIA
NVDA
+$75.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.56%
2 Technology 14.21%
3 Consumer Discretionary 12.36%
4 Industrials 10.91%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URI icon
1626
United Rentals
URI
$72.3B
-21,223
Closed -$2.95M
UTHR icon
1627
United Therapeutics
UTHR
$22B
-31,964
Closed -$3.74M
VC icon
1628
Visteon
VC
$2.79B
-151,616
Closed -$18.8M
VMI icon
1629
Valmont Industries
VMI
$9.58B
-42,225
Closed -$6.67M
VRA icon
1630
Vera Bradley
VRA
$99.2M
-768,931
Closed -$6.92M
VREX icon
1631
Varex Imaging
VREX
$522M
-271,286
Closed -$9.22M
VRNT
1632
DELISTED
Verint Systems
VRNT
-17,094
Closed -$366K
VRTS icon
1633
Virtus Investment Partners
VRTS
$1.08B
-7,137
Closed -$828K
VSAT icon
1634
Viasat
VSAT
$11.2B
-25,726
Closed -$1.65M
W icon
1635
Wayfair
W
$14.7B
-47,230
Closed -$3.16M
WAL icon
1636
Western Alliance Bancorporation
WAL
$9.05B
-116,755
Closed -$6.19M
WGO icon
1637
Winnebago Industries
WGO
$904M
-62,335
Closed -$2.81M
WRLD icon
1638
World Acceptance Corp
WRLD
$897M
-2,929
Closed -$243K
WST icon
1639
West Pharmaceutical
WST
$24.7B
-50,240
Closed -$4.82M
WTS icon
1640
Watts Water Technologies
WTS
$12.1B
-98,209
Closed -$6.78M
WTW icon
1641
Willis Towers Watson
WTW
$31.4B
-22,397
Closed -$3.45M
WVE icon
1642
Wave Life Sciences
WVE
$1.17B
-61,286
Closed -$1.35M
XRAY icon
1643
Dentsply Sirona
XRAY
$2.86B
-168,992
Closed -$10.1M
XYL icon
1644
Xylem
XYL
$28.5B
-362,673
Closed -$22.8M
ZBH icon
1645
Zimmer Biomet
ZBH
$19B
-135,058
Closed -$15.3M
ZD icon
1646
Ziff Davis
ZD
$1.94B
-6,638
Closed -$427K
ZION icon
1647
Zions Bancorporation
ZION
$10.5B
-85,762
Closed -$4.03M
GAP
1648
The Gap Inc
GAP
$7.4B
-223,152
Closed -$6.7M
MAGN
1649
Magnera Corp
MAGN
$482M
-12,975
Closed -$3.2M
PVLA
1650
Palvella Therapeutics
PVLA
$2.23B
-214
Closed -$103K

Similar funds

Marshall Wace North America's Q4 2017 Portfolio in Review

As of Q4 2017, Marshall Wace North America held 1,826 positions worth $18.1B, up 14% from $15.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.49B of net new capital in Q4 2017, opening 616 new positions and adding to 338 existing holdings. Its largest new stake was Time Warner Inc: 2,188,772 shares worth $200M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Applied Materials, an estimated $162M trimmed.

  • Marshall Wace North America's largest Q4 2017 buy was Time Warner Inc: 2,188,772 shares worth $200M.
  • Marshall Wace North America added most to Boston Scientific in Q4 2017, an estimated $219M increase.
  • Marshall Wace North America's biggest Q4 2017 reduction was Applied Materials, cutting an estimated $162M.
  • Marshall Wace North America fully exited NVIDIA in Q4 2017, selling an estimated $75.7M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $18.1B portfolio in Q4 2017.
  • Marshall Wace North America opened 616 new positions and closed 491 in Q4 2017.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $18.1B.

Based on Marshall Wace North America's 13F filing for Q4 2017, filed 14 Feb 2018.